2020 - Fellow of the American Academy of Arts and Sciences
2017 - Member of the National Academy of Sciences
2017 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
His primary scientific interests are in Virology, Virus, Immunology, Virus latency and Viral replication. His Virology research incorporates themes from T cell and In vivo. The Virus study combines topics in areas such as Genome, Gene and Provirus.
He combines subjects such as Peripheral blood mononuclear cell and Drug resistance with his study of Immunology. The study incorporates disciplines such as In vitro, Prostratin, Latent Virus, Stem cell and HIV integration in addition to Virus latency. In general Viral replication, his work in Viral entry is often linked to Persistence linking many areas of study.
Robert F. Siliciano focuses on Virology, Immunology, Virus, Viral replication and Viral load. His Virology study incorporates themes from T cell, Immune system and Antiretroviral therapy. His study in the field of Viral disease is also linked to topics like Latency.
His research investigates the connection with Virus and areas like T lymphocyte which intersect with concerns in G0 phase. His Viral replication study combines topics from a wide range of disciplines, such as Reverse transcriptase and Replication. His research integrates issues of RNA, Latent Virus, Virus Activation, Virus Integration and In vivo in his study of Virus latency.
Robert F. Siliciano mostly deals with Virology, Virus, Antiretroviral therapy, Viral load and T cell. He has researched Virology in several fields, including Genome and In vivo. His Virus research is multidisciplinary, incorporating elements of DNA, Cell and Immune system.
Viral load is a subfield of Immunology that he studies. His work in the fields of Immunology, such as Lentivirus, overlaps with other areas such as Psychological intervention. His Memory T cell study, which is part of a larger body of work in T cell, is frequently linked to Latency, bridging the gap between disciplines.
Robert F. Siliciano spends much of his time researching Virology, Virus latency, Immunology, Virus and T cell. His research in Virology intersects with topics in Genome, Provirus and Antiretroviral therapy. His studies in Virus latency integrate themes in fields like Small hairpin RNA, Gene knockdown, Immune system, Transactivation and Virus Activation.
His study in the fields of Viral load under the domain of Immunology overlaps with other disciplines such as Bayes' theorem. His research in T cell focuses on subjects like In vivo, which are connected to Cell culture, Homeostasis, T-cell receptor and In vitro. His study looks at the relationship between Viral replication and fields such as Cell growth, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
Diana Finzi;Monika Hermankova;Theodore Pierson;Lucy M. Carruth.
Science (1997)
Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Diana Finzi;Joel N Blankson;Janet M Siliciano;Joseph Bernard Margolick.
Nature Medicine (1999)
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
Tae Wook Chun;Lucy Carruth;Diana Finzi;Xuefei Shen.
Nature (1997)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.
Janet D Siliciano;Joleen Kajdas;Diana Finzi;Thomas C Quinn;Thomas C Quinn.
Nature Medicine (2003)
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
Ya Chi Ho;Liang Shan;Nina N. Hosmane;Jeffrey Wang.
Cell (2013)
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
Tae Wook Chun;Diana Finzi;Joseph Margolick;Karen Chadwick.
Nature Medicine (1995)
The challenge of viral reservoirs in HIV-1 infection.
Joel N. Blankson;Deborah Persaud;Robert F. Siliciano.
Annual Review of Medicine (2002)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan;Kai Deng;Neeta S. Shroff;Christine M. Durand.
Immunity (2012)
Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy
Theodore Pierson;Justin McArthur;Robert F. Siliciano.
Annual Review of Immunology (2000)
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Susanne Eriksson;Erin H. Graf;Viktor Dahl;Matthew C. Strain.
PLOS Pathogens (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Johns Hopkins University School of Medicine
Johns Hopkins University
Johns Hopkins University
Johns Hopkins University School of Medicine
University of California, San Francisco
Harvard University
Harvard University
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Johns Hopkins University School of Medicine
University of California, San Diego
National Institutes of Health
RWTH Aachen University
University of Massachusetts Amherst
Nanjing University
Universidade de São Paulo
Max Planck Society
University of Arizona
Hebrew University of Jerusalem
University of Reading
Goddard Space Flight Center
Utrecht University
University Hospital of Lausanne
Tokyo Medical and Dental University
University of Hong Kong
Tufts University